These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29433072)

  • 21. Serum Levels of Neuroactive Steroids in First-episode Antipsychotic-naïve Schizophrenic Patients and Its Correlation with Aggression: A Case-control Study.
    Solanki RK; Sharma P; Tyagi A; Singh C
    East Asian Arch Psychiatry; 2017 Jun; 27(2):79-84. PubMed ID: 28652501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats.
    Naert G; Maurice T; Tapia-Arancibia L; Givalois L
    Psychoneuroendocrinology; 2007; 32(8-10):1062-78. PubMed ID: 17928160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of morphine dependence and withdrawal on levels of neurosteroids in rat brain.
    Yan CZ; Hou YN
    Acta Pharmacol Sin; 2004 Oct; 25(10):1285-91. PubMed ID: 15456529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum cortisol and DHEA-S levels in schizophrenic patients with different response to antipsychotic therapy: association with psychopathology.
    Babinkostova Z; Stefanovski B; Janicevic-Ivanovska D; Samardziska V; Stojanovska L
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):175-83. PubMed ID: 26076787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
    Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
    J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA.
    Ritsner MS; Strous RD
    J Psychiatr Res; 2010 Jan; 44(2):75-80. PubMed ID: 19665142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia.
    Strous RD; Maayan R; Lapidus R; Stryjer R; Lustig M; Kotler M; Weizman A
    Arch Gen Psychiatry; 2003 Feb; 60(2):133-41. PubMed ID: 12578430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia.
    Ritsner MS
    Neuroscience; 2011 Sep; 191():91-100. PubMed ID: 21549182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia.
    Ritsner M; Gibel A; Maayan R; Ratner Y; Ram E; Biadsy H; Modai I; Weizman A
    Neuropsychopharmacology; 2005 Oct; 30(10):1913-22. PubMed ID: 15870835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients.
    Ritsner M; Gibel A; Maayan R; Ratner Y; Ram E; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):257-64. PubMed ID: 17107774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Add-On Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Kardashev A; Ratner Y; Ritsner MS
    Clin Schizophr Relat Psychoses; 2018; 12(1):31-41. PubMed ID: 26218236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of neurosteroids on picrotoxin-, bicuculline- and NMDA-induced seizures, and a hypnotic effect of ethanol.
    Członkowska AI; Krzaścik P; Sienkiewicz-Jarosz H; Siemiatkowski M; Szyndler J; Bidziński A; Płaźnik A
    Pharmacol Biochem Behav; 2000 Oct; 67(2):345-53. PubMed ID: 11124400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced steroidogenesis in patients with PCDH19-female limited epilepsy.
    Trivisano M; Lucchi C; Rustichelli C; Terracciano A; Cusmai R; Ubertini GM; Giannone G; Bertini ES; Vigevano F; Gecz J; Biagini G; Specchio N
    Epilepsia; 2017 Jun; 58(6):e91-e95. PubMed ID: 28471529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.
    Iancu I; Tchernihovsky E; Maayan R; Poreh A; Dannon P; Kotler M; Weizman A; Strous RD
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):541-5. PubMed ID: 17346944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen biosynthesis in the stomach: expression of cytochrome P450 17 alpha-hydroxylase/17,20-lyase messenger ribonucleic acid and protein, and metabolism of pregnenolone and progesterone by parietal cells of the rat gastric mucosa.
    Le Goascogne C; Sananès N; Eychenne B; Gouézou M; Baulieu EE; Robel P
    Endocrinology; 1995 Apr; 136(4):1744-52. PubMed ID: 7895686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effects of the neurosteroid allopregnanolone in a mouse model of spontaneous motoneuron degeneration.
    Meyer M; Garay LI; Kruse MS; Lara A; Gargiulo-Monachelli G; Schumacher M; Guennoun R; Coirini H; De Nicola AF; Gonzalez Deniselle MC
    J Steroid Biochem Mol Biol; 2017 Nov; 174():201-216. PubMed ID: 28951257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjunctive Pregnenolone Ameliorates the Cognitive Deficits in Recent-Onset Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Kreinin A; Bawakny N; Ritsner MS
    Clin Schizophr Relat Psychoses; 2017; 10(4):201-210. PubMed ID: 24496044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurosteroids in the mouse brain: behavioral and pharmacological effects of a 3 beta-hydroxysteroid dehydrogenase inhibitor.
    Young J; Corpéchot C; Perché F; Eychenne B; Haug M; Baulieu EE; Robel P
    Steroids; 1996 Mar; 61(3):144-9. PubMed ID: 8852832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology.
    Strous RD; Maayan R; Lapidus R; Goredetsky L; Zeldich E; Kotler M; Weizman A
    Schizophr Res; 2004 Dec; 71(2-3):427-34. PubMed ID: 15474914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association among serum cortisol, dehydroepiandrosterone-sulfate levels and psychiatric symptoms in men with chronic schizophrenia.
    Peng R; Li Y
    Compr Psychiatry; 2017 Jul; 76():113-118. PubMed ID: 28482249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.